rediff.com
e.g. Tata motors, Reliance MF, 500570
GlaxoSmithKline Pharmaceuticals Ltd. - Research Center
500660 GLAXO Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Quarterly results in brief
(Rs crore)
Sep' 24 Jun' 24 Mar' 24 Dec' 23 Sep' 23
Sales 1,000.05 811.00 910.87 804.98 953.38
Operating profit 318.95 229.42 255.31 217.51 286.58
Interest 0.27 0.37 0.77 0.32 0.43
Gross profit 350.87 264.90 284.41 245.53 314.62
EPS (Rs) 14.68 10.72 11.40 2.69 12.72
Quarterly  results in details
Sep' 24 Jun' 24 Mar' 24 Dec' 23 Sep' 23
Other income 32.19 35.85 29.87 28.34 28.47
Stock adjustment 22.62 -13.26 -98.90 63.93 9.71
Raw material 137.25 133.33 192.29 87.52 79.71
Power and fuel - - - - -
Employee expenses 150.71 151.28 172.83 141.35 145.21
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 370.52 310.23 389.34 294.67 432.17
Provisions made - - - - -
Depreciation 16.86 16.41 18.10 17.11 18.11
Taxation 90.01 66.84 75.63 19.62 80.97
Net profit / loss 248.69 181.65 193.08 45.49 215.54
Extra ordinary item 4.69 - 2.40 -163.31 -
Prior year adjustments - - - - -
Equity capital 169.41 169.41 169.41 169.41 169.41
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 31.89 28.29 28.03 27.02 30.06
GPM (%) 33.99 31.28 30.23 29.46 32.04
NPM (%) 24.09 21.45 20.52 5.46 21.95
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close